Tuberculosis
Volume 87, Issue 1 , Pages 44-52, January 2007

Volatile biomarkers of pulmonary tuberculosis in the breath

  • Michael Phillips

      Affiliations

    • Menssana Research Inc., Fort Lee, NJ 07024, USA
    • Department of Medicine, New York Medical College, Valhalla, NY, USA
    • Corresponding Author InformationCorresponding author. Menssana Research, Inc., 1 Horizon Road, Suite 1415, Fort Lee, NJ 07024, USA. Tel./fax: 2018867004.
  • ,
  • Renee N. Cataneo

      Affiliations

    • Menssana Research Inc., Fort Lee, NJ 07024, USA
  • ,
  • Rany Condos

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Bellevue Chest Service, NYU School of Medicine, New York, NY, USA
  • ,
  • Gerald A. Ring Erickson

      Affiliations

    • Infometrix, Inc, Woodinville, WA, USA
  • ,
  • Joel Greenberg

      Affiliations

    • Menssana Research Inc., Fort Lee, NJ 07024, USA
    • Deceased.
  • ,
  • Vincent La Bombardi

      Affiliations

    • Saint Vincent's Medical Center, New York, NY, USA
  • ,
  • Muhammad I. Munawar

      Affiliations

    • Menssana Research Inc., Fort Lee, NJ 07024, USA
  • ,
  • Olaf Tietje

      Affiliations

    • SystAim GmbH, Pfingstweidstr. 31a, CH 8005 Zürich, Switzerland

Received 14 December 2005; received in revised form 8 March 2006; accepted 10 March 2006. published online 26 April 2006.

Summary 

Pulmonary tuberculosis may alter volatile organic compounds (VOCs) in breath because Mycobacteria and oxidative stress resulting from Mycobacterial infection both generate distinctive VOCs. The objective of this study was to determine if breath VOCs contain biomarkers of active pulmonary tuberculosis. Head space VOCs from cultured Mycobacterium tuberculosis were captured on sorbent traps and assayed by gas chromatography/mass spectroscopy (GC/MS). One hundred and thirty different VOCs were consistently detected. The most abundant were naphthalene, 1-methyl-, 3-heptanone, methylcyclododecane, heptane, 2,2,4,6,6-pentamethyl-, benzene, 1-methyl-4-(1-methylethyl)-, and cyclohexane, 1,4-dimethyl-.

Breath VOCs were assayed by GC/MS in 42 patients hospitalized for suspicion of pulmonary tuberculosis and in 59 healthy controls. Sputum cultures were positive for Mycobacteria in 23/42 and negative in19/42 patients. Breath markers of oxidative stress were increased in all hospitalized patients . Pattern recognition analysis and fuzzy logic analysis of breath VOCs independently distinguished healthy controls from hospitalized patients with 100% sensitivity and 100% specificity. Fuzzy logic analysis identified patients with positive sputum cultures with 100% sensitivity and 100% specificity (95.7% sensitivity and 78.9% specificity on leave-one-out cross-validation); breath VOC markers were similar to those observed in vitro, including naphthalene, 1-methyl- and cyclohexane, 1,4-dimethyl-. Pattern recognition analysis identified patients with positive sputum cultures with 82.6% sensitivity (19/23) and 100% specificity (18/18), employing 12 principal components from 134 breath VOCs.

We conclude that volatile biomarkers in breath were sensitive and specific for pulmonary tuberculosis: the breath test distinguished between “sick versus well” i.e. between normal controls and patients hospitalized for suspicion of pulmonary tuberculosis, and between infected versus non-infected patients i.e. between those whose sputum cultures were positive or negative for Mycobacteria.

Keywords: Volatile organic compounds, Breath, Pulmonary tuberculosis, Diagnosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1472-9792(06)00052-7

doi:10.1016/j.tube.2006.03.004

Tuberculosis
Volume 87, Issue 1 , Pages 44-52, January 2007